Hexavalent vaccine - a combination vaccine against diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B

Folkehelseinstituttet

The Norwegian Institute of Public Health would like to procure diphtheria, tetanus, whooping cough, polio, Haemophilus influenza type B, and hepatitis B combination vaccines (hexavalent vaccine) for babies in the Norwegian child vaccination programme. The procurement is carried out on behalf of the Ministry of Health and Care Services (HOD).
The contest is being held electronically in the CTM KGV and information given in the tender management tool, in the notice, and the tender documentation stipulates the rules and terms for the contest.
NIPH aims to award a contract to one tenderer for a contract period of 2+1+1 years, calculated from 01.01.2024, with the last two years being option years. NIPH would like the first delivery at the latest by the end of the 1st quarter of 2024.

Frist

Fristen for mottak av tilbud var 2023-08-31. Anskaffelsen ble publisert 2023-07-03.

Hvem? Hva? Hvor?
Anskaffelseshistorikk
Dato Dokument
2023-07-03 Kunngjøring av konkurranse
Kunngjøring av konkurranse (2023-07-03)
Gjenstand
Anskaffelsens omfang
Tittel: Vaccines
Referansenummer: 23/01723
Kort beskrivelse:
The Norwegian Institute of Public Health would like to procure diphtheria, tetanus, whooping cough, polio, Haemophilus influenza type B, and hepatitis B combination vaccines (hexavalent vaccine) for babies in the Norwegian child vaccination programme. The procurement is carried out on behalf of the Ministry of Health and Care Services (HOD). The contest is being held electronically in the CTM KGV and information given in the tender management tool, in the notice, and the tender documentation stipulates the rules and terms for the contest. NIPH aims to award a contract to one tenderer for a contract period of 2+1+1 years, calculated from 01.01.2024, with the last two years being option years. NIPH would like the first delivery at the latest by the end of the 1st quarter of 2024.
Vis mer
Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Varer
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS), med deltakelse av GPA-land
Felles innkjøpsordliste (CPV)
Kode: Vaksiner 📦
Tilleggs-CPV: Vaksiner mot difteri, kikhoste og stivkrampe 📦
Utførelsessted
NUTS-region: Norge 🏙️

Prosedyre
Prosedyretype: Åpen anbudskonkurranse
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Det mest økonomisk fordelaktige tilbudet

Oppdragsgiver
Identitet
Land: Norge 🇳🇴
Type tildelende myndighet: Departement eller annen nasjonal eller føderal myndighet
Navn på tildelende myndighet: Folkehelseinstituttet
Postadresse: Lovisenberggata 8
Postnummer: 0456
Poststed: Oslo
Kontakt
Internettadresse: http://www.fhi.no 🌏
E-post: ole.andreas.fuglesang@fhi.no 📧
Telefon: +47 21076629 📞
URL for dokumenter: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=372159&B=DFO 🌏
URL for deltakelse: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=372159&B=DFO 🌏

Referanse
Datoer
Sendt dato: 2023-07-03 📅
Innleveringsfrist: 2023-08-31 📅
Publiseringsdato: 2023-07-07 📅
Identifikatorer
Kunngjøringsnummer: 2023/S 129-412898
OJ-S-utgave: 129
Tilleggsinformasjon
The procurement's total value, as stated in the notice point II.2.6) Estimated Value, is based on approved maximum prices (AIP).

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The Norwegian Institute of Public Health would like to procure diphtheria, tetanus, whooping cough, polio, Haemophilus influenza type B, and hepatitis B combination vaccines (hexavalent vaccine) for babies in the Norwegian child vaccination programme. The procurement is carried out on behalf of the Ministry of Health and Care Services (HOD).
Vis mer
The contest is being held electronically in the CTM KGV and information given in the tender management tool, in the notice, and the tender documentation stipulates the rules and terms for the contest.
NIPH aims to award a contract to one tenderer for a contract period of 2+1+1 years, calculated from 01.01.2024, with the last two years being option years. NIPH would like the first delivery at the latest by the end of the 1st quarter of 2024.
Estimert totalverdi: 420 000 000 NOK 💰
Kort beskrivelse:
The procurement consists of delivery of a hexavalent vaccine (ATC code: J07C A09) for vaccinating babies in the Norwegian child vaccination programme.
The following estimates for the annual number of doses that NIPH needs is based on a year made up of approx. 60,000 persons, and 3 doses are to be given to each person in order to achieve sufficient protection from the diseases.
The estimated annual vaccine requirement will be approx. 180,000 doses (per calendar year).
The estimated maximum scope for the contract period, with the full extension of the contract period (option), is estimated to be approx. 720,000 doses.
The Norwegian Institute of Public Health draws attention to the fact that this is only an estimate and the contracting authority is not bound by the estimated volume.
The Norwegian Institute of Public Health will, in accordance with the contract, procure a minimum volume 160,000 doses per calendar year in the contract period. (Supply agreement point 3.2).
Beyond the minimum volume, the volume that the Norwegian Public Health Authority will eventually order, will depend on demand.
The Norwegian Public Health Institute is not obligated to submit orders beyond the minimum requirement.
Estimert verdi eksklusive mva: 420 000 000 NOK 💰
Varighet: 24 måneder
Beskrivelse av fornyelser:
The contract period is 2 years, with an option for 1+1 year extension. The option for an extension will be automatically taken up for one year at a time, unless the contracting authority gives notice on the contract in accordance with the Supply Agreement, point 17. The contracting authority aims to sign the contract shortly after the procurement is implemented.
Vis mer
Beskrivelse av opsjoner:
The contract period is 2 years, with an option for 1+1 year extension. The option for an extension will be automatically taken up for one year at a time, unless the contracting authority gives notice on the contract in accordance with the Supply Agreement, point 17. The contracting authority aims to sign the contract shortly after the procurement is implemented.
Vis mer
Tilleggsinformasjon:
The procurement's total value, as stated in the notice point II.2.6) Estimated Value, is based on approved maximum prices (AIP).

Juridisk, økonomisk, finansiell og teknisk informasjon
Vilkår for deltakelse
Egnethet til å utøve yrkesvirksomheten:
Tenderers must be registered in a company register, professional register or a trade register in the country where the tenderer is established.
Documentation requirement:
Norwegian companies: Company registration certificate
Foreign tenderers: Verification showing that the tenderer is registered in a company register, professional register or a commerce register in the country where the tenderer is established.
Økonomisk og finansiell stilling:
Tenderers must have sufficient economic and financial capacity to fulfil the contract. Creditworthiness with no requirement for guarantees will be sufficient to meet the requirement.
Documentation requirement:
Credit assessment based on the most recent accounting figures. The rating must be carried out by a credit rating agency with a licence to provide such service.
Teknisk og faglig kapasitet:
Tenderers must have the requisite permissions to be able to fulfil the contract.
Documentation requirement:
If the tenderer is the manufacturer of the vaccine, permission must be presented from relevant EU/EEA authorities to manufacture pharmaceuticals.
If the tenderer is not the manufacturer of the vaccine, the requisite permissions from relevant EU/EEA authorities to trade in pharmaceuticals must be presented.
If the tenderer imports the vaccine, the import license that includes the offered vaccine must be presented.
Kontraktutførelse
Vilkår for kontraktoppfyllelse:
• The Norwegian Institute of Public Health requires ethical and socially responsible production. (Supply agreement point 12, 12.1 – 12.3).
• Tenderers must be a member of the Legemiddelansvarsforeningen [Pharmaceutical Liability Association] (Supply Agreement, point 11.2)
The Norwegian Institute of Public Health (NIPH) can re-sell, non-distributed, vaccine doses (Supply Agreement, point 18.1)
• NIPH is, for every year of the entire contract period, bound to procure a stated minimum number of doses (Supply Agreement point 3.2)
• The tenderer is, for every year of the entire contract period, obliged to deliver up to a stated maximum number of doses (Supply Agreement point 3.3)
• First delivery: The tenderer is obliged to deliver minimum 45,000 doses by 31.03.2024

Prosedyre
Rettslig grunnlag: 32014L0024
Tidspunkt for mottak av tilbud: 13:00
Språk som tilbud eller forespørsler om deltakelse kan sendes inn på: engelsk 🗣️
norsk 🗣️
Tilbudets gyldighetsperiode: 2023-11-15 📅
Dato for åpning av tilbud: 2023-08-31 📅
Tidspunkt for åpning av tilbud: 13:00
Sted: Tenders will be opened electronically in the contracting authority's KGV system.
Tilleggsinformasjon:
Two employees with access to the KGV system must log in and each carry out their individual opening of the tenders.
Tildelingskriterier
Kvalitetskriterium (navn): quality
Kvalitetskriterium (vekting): 30
Pris (vekting): 70

Oppdragsgiver
Identitet
Nasjonalt registreringsnummer: 983 744 516
Kontakt
Kontaktpunkt: Ole Andreas Fuglesang
Adresse til kjøperprofilen: https://eu.eu-supply.com/ctm/Company/CompanyInformation/Index/346372 🌏
URL for dokumenter: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=372159&B=DFO 🌏

Referanse
Tilleggsinformasjon
Changes in responsibility for vaccine procurements from 01.01.2024
The revised national budget for 2023 included notified changes to health management, including a proposal to transfer responsibility for vaccine procurements from NIPH to the Norwegian Medicines Agency / Directorate for Medical Products (SLV/DMP) with effect from 01.01.2024.
Vis mer
Per June 2023, a project has been started to clarify how the responsibility is to be transferred. At the time of this notice, the transfer details have not been clarified. If changes are decided that are of importance for signed contracts, the contract can be transferred from NIPH to SLV/DMP or another public entity. NIPH will try to keep affected tenderers informed.
Vis mer

Utfyllende informasjon
Klageinstans
Navn: Oslo tingrett
Postadresse: Postboks 2106 Vika
Poststed: oslo
Postnummer: 0125
Land: Norge 🇳🇴
Internettadresse: https://www.domstol.no/no/domstoler/tingrett/oslo-tingrett/ 🌏
Kilde: OJS 2023/S 129-412898 (2023-07-03)
Nye anskaffelser i relaterte kategorier 🆕
Relaterte søk 🔍
Produkter/tjenester:
Medisinsk utstyr, legemidler og utstyr... Farmasøytiske produkter Antiinfektive midler for systemisk bruk,... Antiinfektive midler for systemisk bruk Vaksiner Vaksiner mot difteri, kikhoste og stivkrampe Vaksiner mot difteri og stivkrampe Poliovaksiner Vaksiner mot hepatitt B